SEC Form 4 · accession 0001209191-18-016047
Skye Bioscience, Inc. · SKYE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Emerald Health Sciences Inc.
10% Owner
Period of report
Jan 24, 2018
Accepted (ET)
Mar 2, 2018 · 7:46 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001516551
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 24, 2018 | X | 1,781,250 | $0.001 | A | 40,781,250 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock Warrant (Right to Buy) | $0.001 | Jan 24, 2018 | X | 1,781,250 | D | Aug 20, 2015 | Aug 20, 2020 | Common Stock | 1,781,250 | 0 | D |